These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 30456352)
61. Chemical synthesis and in silico molecular modeling of novel pyrrolyl benzohydrazide derivatives: Their biological evaluation against enoyl ACP reductase (InhA) and Mycobacterium tuberculosis. Joshi SD; More UA; Dixit SR; Balmi SV; Kulkarni BG; Ullagaddi G; Lherbet C; Aminabhavi TM Bioorg Chem; 2017 Dec; 75():181-200. PubMed ID: 28961440 [TBL] [Abstract][Full Text] [Related]
62. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from south-central in China. Yu XL; Wen ZL; Chen GZ; Li R; Ding BB; Yao YF; Li Y; Wu H; Guo XK; Wang HH; Zhang SL J Antibiot (Tokyo); 2014 Apr; 67(4):291-7. PubMed ID: 24326341 [TBL] [Abstract][Full Text] [Related]
63. Facing Antitubercular Resistance: Identification of Potential Direct Inhibitors Targeting InhA Enzyme and Generation of 3D-pharmacophore Model by in silico Approach. El Haddoumi G; Mansouri M; Bendani H; Bouricha EM; Kandoussi I; Belyamani L; Ibrahimi A Adv Appl Bioinform Chem; 2023; 16():49-59. PubMed ID: 37143606 [TBL] [Abstract][Full Text] [Related]
64. New InhA Inhibitors Based on Expanded Triclosan and Chetty S; Armstrong T; Sharma Kharkwal S; Drewe WC; De Matteis CI; Evangelopoulos D; Bhakta S; Thomas NR Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33919737 [TBL] [Abstract][Full Text] [Related]
65. Identification of potential inhibitor targeting enoyl-acyl carrier protein reductase (InhA) in Mycobacterium tuberculosis: a computational approach. Shanthi V; Ramanathan K 3 Biotech; 2014 Jun; 4(3):253-261. PubMed ID: 28324429 [TBL] [Abstract][Full Text] [Related]
66. Design, Synthesis and Molecular Docking of Novel Acetophenone-1,2,3-Triazoles Containing Compounds as Potent Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors. Albelwi FF; Abdu Mansour HM; Elshatanofy MM; El Kilany Y; Kandeel K; Elwakil BH; Hagar M; Aouad MR; El Ashry ESH; Rezki N; El Sawy MA Pharmaceuticals (Basel); 2022 Jun; 15(7):. PubMed ID: 35890098 [TBL] [Abstract][Full Text] [Related]
67. Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug. Mori G; Orena BS; Chiarelli LR; Degiacomi G; Riabova O; Sammartino JC; Makarov V; Riccardi G; Pasca MR Front Microbiol; 2020; 11():292. PubMed ID: 32158439 [TBL] [Abstract][Full Text] [Related]
68. Target Identification of Mugumbate G; Mendes V; Blaszczyk M; Sabbah M; Papadatos G; Lelievre J; Ballell L; Barros D; Abell C; Blundell TL; Overington JP Front Pharmacol; 2017; 8():681. PubMed ID: 29018348 [TBL] [Abstract][Full Text] [Related]
69. Ethambutol targets the glutamate racemase of Mycobacterium tuberculosis-an enzyme involved in peptidoglycan biosynthesis. Pawar A; Jha P; Konwar C; Chaudhry U; Chopra M; Saluja D Appl Microbiol Biotechnol; 2019 Jan; 103(2):843-851. PubMed ID: 30456576 [TBL] [Abstract][Full Text] [Related]
70. Regulation and overexpression studies of YidC in Mycobacterium tuberculosis. Thakur P; Choudhary E; Pareek M; Agarwal N Sci Rep; 2018 Nov; 8(1):17114. PubMed ID: 30459465 [TBL] [Abstract][Full Text] [Related]
71. Pyrazolo[1,5- a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis. Lu X; Williams Z; Hards K; Tang J; Cheung CY; Aung HL; Wang B; Liu Z; Hu X; Lenaerts A; Woolhiser L; Hastings C; Zhang X; Wang Z; Rhee K; Ding K; Zhang T; Cook GM ACS Infect Dis; 2019 Feb; 5(2):239-249. PubMed ID: 30485737 [TBL] [Abstract][Full Text] [Related]
72. Inhibition of Pseudomonas aeruginosa and Mycobacterium tuberculosis disulfide bond forming enzymes. Landeta C; McPartland L; Tran NQ; Meehan BM; Zhang Y; Tanweer Z; Wakabayashi S; Rock J; Kim T; Balasubramanian D; Audette R; Toosky M; Pinkham J; Rubin EJ; Lory S; Pier G; Boyd D; Beckwith J Mol Microbiol; 2019 Apr; 111(4):918-937. PubMed ID: 30556355 [TBL] [Abstract][Full Text] [Related]
73. Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria. Lee BS; Kalia NP; Jin XEF; Hasenoehrl EJ; Berney M; Pethe K J Biol Chem; 2019 Feb; 294(6):1936-1943. PubMed ID: 30530783 [TBL] [Abstract][Full Text] [Related]
74. Application of machine learning techniques to tuberculosis drug resistance analysis. Kouchaki S; Yang Y; Walker TM; Sarah Walker A; Wilson DJ; Peto TEA; Crook DW; ; Clifton DA Bioinformatics; 2019 Jul; 35(13):2276-2282. PubMed ID: 30462147 [TBL] [Abstract][Full Text] [Related]
75. Structural Basis for Inhibition of Enoyl-[Acyl Carrier Protein] Reductase (InhA) from Mycobacterium tuberculosis. de Ávila MB; Bitencourt-Ferreira G; de Azevedo WF Curr Med Chem; 2020; 27(5):745-759. PubMed ID: 30501592 [TBL] [Abstract][Full Text] [Related]
76. Targeting the Mycobacterium ulcerans cytochrome bc Scherr N; Bieri R; Thomas SS; Chauffour A; Kalia NP; Schneide P; Ruf MT; Lamelas A; Manimekalai MSS; Grüber G; Ishii N; Suzuki K; Tanner M; Moraski GC; Miller MJ; Witschel M; Jarlier V; Pluschke G; Pethe K Nat Commun; 2018 Dec; 9(1):5370. PubMed ID: 30560872 [TBL] [Abstract][Full Text] [Related]